Investigators seeking to buy Dihexa for in vitro and preclinical research require fully characterized, analytical-grade material. Dihexa (PNB-0408) is a synthetic peptide derivative studied for its high-affinity binding to Hepatocyte Growth Factor (HGF) and downstream activation of the c-Met receptor tyrosine kinase pathway. PX1 Research supplies USA-manufactured Dihexa verified above 99% purity via HPLC and Mass Spectrometry, accompanied by lot-specific Certificates of Analysis and expedited same-day dispatch from our California and Arizona facilities.
Investigators seeking to buy Dihexa for in vitro and preclinical research require fully characterized, analytical-grade material. Dihexa (PNB-0408) is a synthetic peptide derivative studied for its high-affinity binding to Hepatocyte Growth Factor (HGF) and downstream activation of the c-Met receptor tyrosine kinase pathway. PX1 Research supplies USA-manufactured Dihexa verified above 99% purity via HPLC and Mass Spectrometry, accompanied by lot-specific Certificates of Analysis and expedited same-day dispatch from our California and Arizona facilities.
Dihexa, designated in scientific literature as PNB-0408 or N-hexanoic-Tyr-Ile-(6-aminohexanoic amide), is a low-molecular-weight oligopeptide derivative synthesized to overcome the rapid metabolic degradation typical of endogenously produced peptide ligands. Derived structurally from the N-terminal sequence of angiotensin IV, Dihexa was engineered to maintain exceptional metabolic stability while preserving potently selective interactions with specific growth factor systems.
In chemical structure, Dihexa combines hydrophobic fatty acid modifications with a modified dipeptide backbone. This structural configuration grants the molecule enhanced lipophilicity and structural rigidity compared to native linear peptides. Researchers actively analyze Dihexa within cognitive research peptides frameworks, specifically focusing on its stability profile in culture media, cellular permeability parameters, and resistance to standard peptidases.
When procurement teams look to buy dihexa for laboratory evaluation, analytical confirmation of identity is vital. Molecular weight verification via High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC/MS) ensures that the synthesized compound accurately matches the theoretical mass of 501.7 g/mol without trace capped intermediates, unreacted reagents, or structural isomers.
The primary biochemical focus of Dihexa research involves its interaction with Hepatocyte Growth Factor (HGF) and its transmembrane receptor tyrosine kinase, c-Met (also designated as the MET proto-oncogene product). Preclinical studies suggest that Dihexa functions by binding directly to HGF with high affinity, facilitating dimerization and augmenting HGF-induced activation of c-Met autophosphorylation.
Activation of the HGF/c-Met signaling axis triggers intracellular downstream cascades, including the Phosphoinositide 3-kinase (PI3K)/Akt and Mitogen-Activated Protein Kinase (MAPK)/ERK pathways. In cell culture environments and organotypic slice preparations, activation of these pathways plays a central role in dendritic arborization, spinogenesis, and functional synaptic plasticity. In vitro models demonstrate that nanomolar concentrations of Dihexa enhance the formation of new functional synaptic connections—a phenomenon frequently quantified via post-synaptic density 95 (PSD-95) expression levels.
Unlike conventional neurotrophic factors such as Brain-Derived Neurotrophic Factor (BDNF) or Nerve Growth Factor (NGF), which possess large molecular masses and brief plasma half-lives, small-molecule HGF mimetics like Dihexa permit robust experimental manipulation of the HGF/c-Met axis in diverse assay formats. Laboratories investigating neuroplasticity compounds utilize Dihexa to map structural remodeling dynamics in hippocampal and cortical neuronal cultures.
Sourcing raw materials for rigorous scientific experimentation demands strict adherence to quality assurance standards. When evaluating options for high purity research compounds for sale, research institutions must look beyond standard vendor specifications and demand transparent analytical documentation.
At PX1 Research, every production lot of Dihexa undergoes comprehensive quality testing in ISO 17025 accredited analytical facilities. We establish lot validity through five essential analytical parameters:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity, ensuring target compound concentration exceeds 99.0% while confirming the absence of related peptide impurities. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass and confirms correct structural identity. 3. Endotoxin Quantitation (LAL Assay): Verifies that bacterial endotoxin levels remain strictly under 0.05 EU/mg, preventing confounding inflammatory responses in cell culture models. 4. Residual Solvent Analysis (GC-MS): Assures complete removal of synthesis reagents and volatile organic solvents. 5. Physical Appearance and Solubility Testing: Confirms consistent physical characteristics and rapid dissolution parameters in recommended solvent systems.
By enforcing these strict criteria, PX1 Research provides primary investigators with consistent lot-to-lot reproducibility, mitigating experimental variance caused by chemical impurities or biological contamination.
To contextualize Dihexa's activity within neurobiology research, researchers often compare its binding kinetics, signaling mechanisms, and stability to other small molecules and peptides evaluated in synaptic plasticity assays.
For example, while Dihexa operates primarily through HGF/c-Met potentiation, compounds such as the Semax research compound interact predominantly with central melanocortin receptors and modulate BDNF expression. Similarly, the Selank peptide exerts regulatory effects via allosteric modulation of GABA-A receptors and immune-mediated cytokine pathways. In contrast, researchers studying extracellular matrix repair and cell migration frequently incorporate the BPC-157 research peptide alongside HGF modulators to evaluate synergistic tissue response cascades.
The table below outlines fundamental structural and mechanistic distinctions among these common laboratory compounds:
• Dihexa: Small molecule / oligopeptide derivative | Primary Target: HGF/c-Met Receptor | Main Preclinical Focus: Synaptogenesis, dendritic spine density • Semax: Heptapeptide ACTH analog | Primary Target: Melanocortin / BDNF systems | Main Preclinical Focus: Neuroprotection, central BDNF expression • Selank: Bi-functional synthetic heptapeptide | Primary Target: GABA-A / Enkephalin modulation | Main Preclinical Focus: Anxiolytic pathways, cytokine balance • BPC-157: 15-amino-acid synthetic peptide | Primary Target: FAK/Paxillin / VEGFR signaling | Main Preclinical Focus: Tissue repair, focal adhesion, angiogenesis
Exploring these distinct mechanisms allows research teams to select the exact pathways required for target validation and multi-target comparative screening. Additional detailed documentation across these families is accessible in our main PX1 Research Hub.
In preclinical neuroscience, Dihexa is widely deployed to investigate structural neuroplasticity in primary neuronal cultures, organotypic brain slices, and immortalized neural cell lines. Researchers quantifying spine morphology typically utilize confocal fluorescence microscopy coupled with GFP-tagged actin expression to monitor real-time spinogenesis.
In vitro experiments routinely test Dihexa across concentration gradients ranging from 10 picomolar (pM) to 100 nanomolar (nM). Data from primary hippocampal neuron cultures suggest that low nanomolar exposures induce significant increases in dendritic branch order and mushroom-type spine frequency within 24 to 72 hours of administration.
Furthermore, researchers utilize western blot analysis and enzyme-linked immunosorbent assays (ELISA) to monitor the phosphorylation state of Met (Tyr1234/1235), Akt (Ser473), and ERK1/2 (Thr202/Tyr204). These quantitative biochemical markers allow investigators to trace signal transduction kinetics under controlled experimental variables.
Proper reconstitution and stock preparation are essential to maintain the structural integrity and bioactivity of Dihexa in experimental settings. Due to its hydrophobic N-terminal hexanoyl group, Dihexa exhibits distinct solubility characteristics compared to hydrophilic linear peptides.
For optimal dissolution, researchers should avoid direct reconstitution in pure aqueous buffers like Phosphate-Buffered Saline (PBS) at high concentrations. Instead, the compound should first be dissolved in high-purity dimethyl sulfoxide (DMSO) or ethanol to create a concentrated master stock solution (e.g., 10 mM to 50 mM).
Once fully solubilized in organic vehicle, stock solutions can be diluted into culture media or aqueous assay buffers, maintaining final DMSO or ethanol concentrations below 0.1% v/v to avoid solvent-induced cellular toxicity. For researchers requiring tailored bulk concentrations or custom formulations, explore options via our wholesale research accounts portal.
Maintaining chemical stability preserves experimental fidelity over time. Dihexa is supplied by PX1 Research in a lyophilized state inside sealed, amber glass vials to prevent photodegradation and moisture absorption.
Lyophilized compound storage guidelines: • Long-term storage (12–24 months): Store desiccated at -20°C. • Extended archival storage (>24 months): Store desiccated at -80°C. • Room temperature exposure: Minimize ambient exposure during physical transfers; lyophilized Dihexa remains stable at room temperature for brief shipping periods.
Reconstituted stock solution guidelines: • DMSO stock solutions stored at -20°C maintain chemical stability for up to 3 to 6 months. • Avoid repeated freeze-thaw cycles by dispensing master stock into single-use micro-aliquots prior to freezing. • Aqueous working dilutions should be prepared fresh daily immediately prior to assay execution.
Research laboratories, university departments, and biotechnology facilities require predictable supply chains and uncompromising quality control. PX1 Research operates state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) standards, ensuring every batch meets international scientific standards.
When institutions select PX1 Research to buy dihexa or explore our complete catalog of lyophilized compounds, they gain access to standardized supply benefits:
• Verified Purity: Every lot is analyzed by independent third-party laboratories using RP-HPLC and MS. • Comprehensive Documentation: Full COA, MS spectra, and HPLC chromatograms are available for download per batch. • Rapid Domestic Dispatch: Orders processed Monday through Friday before cut-off times ship same-day from our dual fulfillment centers in California and Arizona. • Scalable Packaging: Available from single-vial analytical quantities up to multi-gram bulk supply for large-scale preclinical studies.
To review full analytical datasets or place institutional purchase orders, visit the dedicated product page for Dihexa research compound.
Where can institutional laboratories buy dihexa with verified purity?
Institutional laboratories can buy Dihexa directly from PX1 Research. We provide USA-manufactured, analytical-grade Dihexa (>99% purity) accompanied by lot-specific third-party COAs, HPLC chromatograms, and mass spectrometry validation.
What criteria should be evaluated when sourcing high purity research compounds for sale?
When evaluating high purity research compounds for sale, researchers must verify third-party analytical documentation including RP-HPLC for chemical purity (>98-99%), Mass Spectrometry for identity confirmation, LAL assays for endotoxin quantification (<0.05 EU/mg), and proof of domestic manufacturing under strict quality control standards.
What is the primary molecular mechanism of Dihexa in preclinical research?
Dihexa functions as a small-molecule mimetic of Hepatocyte Growth Factor (HGF). Preclinical studies demonstrate that it binds HGF with high affinity, enhancing HGF-mediated activation of the c-Met receptor tyrosine kinase and driving downstream PI3K/Akt and MAPK/ERK signaling pathways associated with synaptogenesis.
How does Dihexa interact with the HGF/c-Met pathway?
In vitro assays indicate that Dihexa stabilizes and potentiates HGF binding to its receptor, c-Met. This interaction induces receptor autophosphorylation, initiating intracellular signaling cascades that promote dendritic spine formation and structural synaptic remodeling.
What solvent is recommended to reconstitute Dihexa for in vitro assays?
Due to its lipophilic nature, Dihexa should first be dissolved in dimethyl sulfoxide (DMSO) or 100% laboratory-grade ethanol to form a concentrated master stock. This stock can subsequently be diluted into aqueous culture media, ensuring final organic solvent levels remain below 0.1% v/v.
How does Dihexa compare to other neuroplasticity compounds like Semax or Selank?
Dihexa acts specifically on the HGF/c-Met receptor axis to promote synaptogenesis and spinogenesis. Semax operates primarily through melanocortin receptors and BDNF expression, while Selank modulates GABA-A receptors and immune signaling pathways. Each targets distinct mechanisms within central nervous system research.
What analytical testing protocols accompany Dihexa orders from PX1 Research?
Every lot of Dihexa undergo Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity, Electrospray Ionization Mass Spectrometry (ESI-MS) for identity confirmation, Limulus Amebocyte Lysate (LAL) testing for endotoxin detection, and physical solubility testing.
What are the recommended laboratory storage conditions for Dihexa?
Lyophilized Dihexa should be stored desiccated at -20°C for up to 24 months, or -80°C for long-term storage. Reconstituted stock solutions in DMSO should be aliquoted to prevent freeze-thaw cycles and kept at -20°C for up to 3–6 months.
Are bulk and institutional quantities of Dihexa available for large-scale studies?
Yes, PX1 Research provides bulk procurement options for research universities, biotechnology facilities, and institutional laboratories through our wholesale program, offering scalable batch sizes with consistent lot traceability.
What are the domestic shipping fulfillment timelines for research compound orders?
Orders placed Monday through Friday prior to standard cut-off times ship same-day from PX1 Research facilities located in California and Arizona, ensuring minimal transit time for sensitive research reagents.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.